Pavion Blue Capital, LLC Amgen Inc Transaction History

Pavion Blue Capital, LLC

$221 Million
Q2 2025

A detailed history of Pavion Blue Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Pavion Blue Capital, LLC holds 2,911 shares of AMGN stock, worth $829,576. This represents 0.37% of its overall portfolio holdings.

Number of Shares

2,911

Previous 3,034 4.05%

Holding current value

$829,576

Previous $945,000 14.07%

% of portfolio

0.37%

Previous 0.46%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 01, 2025	SELL	$262.28 - $309.85 $32,260 - $38,111	-123 Reduced 4.05%	2,911 $812,000
Q1 2025 May 05, 2025	SELL	$258.59 - $327.36 $15,773 - $19,968	-61 Reduced 1.97%	3,034 $945,000
Q4 2024 Feb 03, 2025	SELL	$258.78 - $328.31 $517 - $656	-2 Reduced 0.06%	3,095 $806,000
Q2 2024 Jul 15, 2024	SELL	$262.75 - $319.31 $9,721 - $11,814	-37 Reduced 1.18%	3,097 $967,000
Q1 2024 Apr 26, 2024	SELL	$268.87 - $324.56 $5,915 - $7,140	-22 Reduced 0.7%	3,134 $891,000
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $28,127 - $31,730	-110 Reduced 3.37%	3,156 $908,000
Q3 2023 Nov 03, 2023	SELL	$218.65 - $271.46 $10,495 - $13,030	-48 Reduced 1.45%	3,266 $877,000
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $428 - $506	2 Added 0.06%	3,314 $735,000
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $4,967 - $6,054	-22 Reduced 0.66%	3,312 $800,000
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $458 - $582	2 Added 0.06%	3,334 $875,000
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $6,509 - $7,341	-29 Reduced 0.86%	3,332 $751,000
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $5,998 - $6,675	26 Added 0.78%	3,361 $818,000
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $438 - $485	2 Added 0.06%	3,335 $806,000
Q4 2021 Jan 28, 2022	BUY	$198.88 - $227.6 $79,552 - $91,040	400 Added 13.64%	3,333 $750,000
Q4 2021 Jan 26, 2022	SELL	$198.88 - $227.6 $109,384 - $125,180	-550 Reduced 15.79%	2,933 $660,000
Q3 2021 Nov 16, 2021	BUY	$212.27 - $248.7 $84,908 - $99,480	400 Added 12.97%	3,483 $741,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $84,695 - $99,231	-399 Reduced 11.46%	3,083 $656,000
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $32,467 - $36,020	-139 Reduced 3.84%	3,482 $849,000
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $19,749 - $23,015	-89 Reduced 2.4%	3,621 $901,000
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $21,854 - $26,024	-101 Reduced 2.65%	3,710 $853,000
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $274,071 - $304,789	1,168 Added 44.19%	3,811 $969,000
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $236,547 - $313,726	1,298 Added 96.51%	2,643 $536,000
Q4 2019 Jan 30, 2020	BUY	$189.21 - $243.2 $254,487 - $327,104	1,345 New	1,345 $324,000

Others Institutions Holding AMGN

# of Institutions

3,271

Shares Held

445M

Call Options Held

7.23M

Put Options Held

6.71M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pavion Blue Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pavion Blue Capital, LLC with notifications on news.

Account

Pavion Blue Capital, LLC Amgen Inc Transaction History